Ranolazine

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 60290-056
  • Package NDC 60290-056-01
  • Package NDC 60290-056-03
  • Application number ANDA214551
  • SPL ID 5e7d2b80-75af-d86d-e063-6294a90a6365
  • SPL set ID a624dc7f-921d-4554-a813-f72dca0133c3
  • UNII A6IEZ5M406
  • RxCUI 616749
  • RxCUI 728231

What the source publishes

Labeler
Umedica Laboratories USA Inc.
Active ingredients
Ranolazine
Form
TABLET, EXTENDED RELEASE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:60290-056_5e7d2b80-75af-d86d-e063-6294a90a6365
{
  "name": "Ranolazine",
  "splId": "5e7d2b80-75af-d86d-e063-6294a90a6365",
  "labels": [
    {
      "setId": "a624dc7f-921d-4554-a813-f72dca0133c3",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a624dc7f-921d-4554-a813-f72dca0133c3",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a624dc7f-921d-4554-a813-f72dca0133c3"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Umedica Laboratories USA Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (60290-056-01)",
      "package_ndc": "60290-056-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20260810"
    },
    {
      "sample": false,
      "description": "6 BLISTER PACK in 1 CARTON (60290-056-03)  / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK",
      "package_ndc": "60290-056-03",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20260810"
    }
  ],
  "productId": "60290-056_5e7d2b80-75af-d86d-e063-6294a90a6365",
  "useDomain": "unknown",
  "dosageForm": "TABLET, EXTENDED RELEASE",
  "productNdc": "60290-056",
  "deaSchedule": null,
  "genericName": "Ranolazine",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "RANOLAZINE",
      "strength": "1000 mg/1"
    }
  ],
  "applicationNumber": "ANDA214551",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20260810",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175427",
      "N0000190114",
      "N0000185503",
      "N0000182137",
      "N0000187061"
    ],
    "upc": [
      "0360290056010"
    ],
    "unii": [
      "A6IEZ5M406"
    ],
    "rxcui": [
      "616749",
      "728231"
    ],
    "spl_set_id": [
      "a624dc7f-921d-4554-a813-f72dca0133c3"
    ],
    "pharm_class_epc": [
      "Anti-anginal [EPC]"
    ],
    "pharm_class_moa": [
      "Cytochrome P450 3A Inhibitors [MoA]",
      "P-Glycoprotein Inhibitors [MoA]",
      "Cytochrome P450 2D6 Inhibitors [MoA]",
      "Organic Cation Transporter 2 Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Umedica Laboratories USA Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:60290-056_5e7d2b80-75af-d86d-e063-6294a90a6365"